Last reviewed · How we verify
NCT04120558: COSTAA
Comparing OutcomeS of Through Knee and Above Knee Amputation
trial testing Qualitative interviews and focus groups in Through Knee Amputation in 40 participants. Status unknown.
30 April 2022
Quick facts
| Lead sponsor | Hull University Teaching Hospitals NHS Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 5 June 2019 |
| Primary completion | 30 April 2022 |
| Estimated completion | 31 October 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Qualitative interviews and focus groups
- Functional mobility tests and questionnaires
Conditions studied
- Through Knee Amputation — all drugs for Through Knee Amputation →
Sponsor
Hull University Teaching Hospitals NHS Trust
Who can join
18 and older, any sex, with Through Knee Amputation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Major lower limb amputation is a life changing surgical procedure to treat complications of diabetes mellitus and peripheral vascular disease. The level of function after amputation is dependent on pre-morbid levels of activity, age, co-morbidities and the level of amputation. The level of amputation performed is determined by level of disease and surgical assessment. Below knee amputation provides the best functional outcomes due to the benefits of keeping the knee intact. When a below knee amputation is not possible, routine practice is to perform an above knee amputation. Greater challenges for rehabilitation present at this level due to the shorter lever. Amputation through the knee is less commonly performed despite its reported benefits which include a long mechanical lever arm, an endbearing stump and greater muscle control. A recent systematic review recommends further comparison of through knee and above knee amputation. The recommended areas of research are gait biomechanics and quality of life for these patient groups. Therefore, the aim of this research is to compare and contrast the long-term functional mobility and quality of life outcomes of limb wearing through knee and above knee amputees. The study will be split into two workstreams, the first focusing on functional outcomes and the second focusing on quality of life using semi-structured interviews.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Through-knee versus above-knee amputation for vascular and non-vascular major lower limb amputations.
Crane H, Boam G, Carradice D, Vanicek N, et al · · 2021 · cited 15× · PMID 34904714 · DOI 10.1002/14651858.cd013839.pub2
Verify or expand the search:
- PubMed search for NCT04120558
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hull University Teaching Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT07502040 — Impact of Exercise Access on Physio Outcomes Post Knee Replacement · NA · not yet recruiting
- NCT07483502 — The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Sur · NA · not yet recruiting
- NCT07427550 — Palliative Care and The Terminally Ill Adults (End of Life) Bill · not yet recruiting
- NCT06876506 — Identification of B Regulatory Cells by Flow Cytometry · not yet recruiting
- NCT07409519 — Nutritional Screening in Cardiovascular Disease · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04120558 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hull University Teaching Hospitals NHS Trust
- Last refreshed: 21 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04120558.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing